[PDF][PDF] Towards New Therapies for Preeclampsia: Restoring Vascular Dysfunction

E Hitzerd - 2020 - repub.eur.nl
Preeclampsia (PE) is a severe placenta-related pregnancy disorder, that complicates
around 5-8% of pregnancies. 1 PE can have detrimental consequences during pregnancy …

New approaches for managing preeclampsia: clues from clinical and basic research

EM George - Clinical therapeutics, 2014 - Elsevier
Purpose One of the most common, and most vexing, obstetric complications is preeclampsia—
a major cause of maternal and perinatal morbidity. Hallmarked by new-onset hypertension …

Pre-eclampsia

B SMYTH - Advanced Therapy in Hypertension and Vascular …, 2006 - books.google.com
Preeclampsia is de novo hypertension with proteinuria at> 20 weeks gestation. ¹ It is the
most life-threatening hypertensive disorder of pregnancy (Table 45-1) and the third leading …

Targeting the vascular dysfunction: Potential treatments for preeclampsia

SA Marshall, AG Cox, LJ Parry, EM Wallace - Microcirculation, 2019 - Wiley Online Library
Preeclampsia is a pregnancy‐specific disorder, primarily characterized by new‐onset
hypertension in combination with a variety of other maternal or fetal signs. The …

Potential targets for the treatment of preeclampsia

CJ Oyston, JL Stanley, PN Baker - Expert opinion on therapeutic …, 2015 - Taylor & Francis
Introduction: Preeclampsia is a disorder of pregnancy, typically characterized by
hypertension and proteinuria observed after the 20th week of gestation. Preeclampsia has …

Future therapies for pre‐eclampsia: beyond treading water

C Fenton, SR Hobson, EM Wallace… - Australian and New …, 2014 - Wiley Online Library
Pre‐eclampsia remains a major burden of disease, accounting for approximately 50,000–
70,000 maternal deaths each year worldwide. Frustratingly, the management of pre …

Novel approaches to combat preeclampsia: from new drugs to innovative delivery

N de Alwis, NK Binder, S Beard, J Tu'uhevaha, S Tong… - Placenta, 2020 - Elsevier
Preeclampsia is a complex disease affecting 2–8% of pregnancies worldwide. It poses
significant risk of maternal and perinatal morbidity and mortality. Despite the rising research …

Treatment of preeclampsia: current approach and future perspectives

E Berzan, R Doyle, CM Brown - Current hypertension reports, 2014 - Springer
Hypertension is the most common medical disorder encountered during pregnancy,
occurring in about 6–8% of pregnancies. Preeclampsia is a pregnancy-specific disorder that …

[PDF][PDF] Treatment of pre-eclampsia: implementing research findings

SV Ramesar, P Gathlram, J Moodley, I Mackraj - Gynecol Obstetric, 2012 - academia.edu
Pre-eclampsia is a complex disease that affects both mother and their developing fetus. Due
to the multifactorial nature of the disease and its undeciphered etiology, we explore the …

Marcelo R. Luizon 1†, Izabela MCA Conceição 1†, Sarah Viana-Mattioli2, Mayara Caldeira-Dias 2, Ricardo C. Cavalli3 and Valeria C. Sandrim 2

P Osei-Owusu, C Chen - … . An International Effort Addressed to Fill …, 2022 - books.google.com
Preeclampsia (PE) is characterized by hypertension after 20 weeks of gestation, which may
be accompanied by proteinuria or thrombocytopenia, renal insufficiency, impaired liver …